EGFR Mutations, ROS1, and ALK Rearrangements in Iranian Non-Small Cell Lung Cancer Patients

Iranian Journal of Blood and Cancer · Published 2025-03-01 · DOI 10.61186/ijbc.17.1.40

Authors being retrieved — see the publisher record. https://doi.org/10.61186/ijbc.17.1.40

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

F8 Gene Splice Donor Mutation (c.1271+1G>A) in Individual with Mild Hemophilia A in Indonesia: A Case Study · Iranian Journal of Blood and Cancer · 2024 · Same journal
Evaluation of the Home Safety and Child-friendly Environment for Children with Bleeding Tendency Disorders · Iranian Journal of Blood and Cancer · 2024 · Same journal
Application of Artificial Intelligence in Celiac Disease: from diagnosis to patient follow-up · Iranian Journal of Blood and Cancer · 2023 · Same journal
Molecular Pathways of Gliomas Involving RNA-Binding Protein Dynamics · Iranian Journal of Blood and Cancer · 2024 · Same journal
Remodeling Methods of TIME for Enhanced Immunotherapy against Non-Melanoma Skin Cancer · Iranian Journal of Blood and Cancer · 2023 · Same journal
Categorized Serum miRNAs as Potential Biomarkers for Predicting the Progression and Prognosis of Colorectal Cancer · Iranian Journal of Blood and Cancer · 2024 · Same journal
Flow Cytometry-based Functional Assay is a Valuable Diagnostic Approach for Confirmation of Heparin-Induced Thrombocytopenia · Iranian Journal of Blood and Cancer · 2024 · Same journal
Artificial intelligence (AI): The next stage of evolution? · Iranian Journal of Blood and Cancer · 2023 · Same journal
Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia · Iranian Journal of Blood and Cancer · 2023 · Same journal
Assessing Neutrophil CD64 Expression: A Key Biomarker for Diagnosing Infections and Evaluating Antibiotic Therapy in Acute Leukemia Patients · Iranian Journal of Blood and Cancer · 2024 · Same journal